Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 4/6 |
Past Performance | 2/6 |
Financial Health | 2/6 |
Dividends | 3/6 |
C.Q. Pharmaceutical Holding Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥4.83 |
52 Week High | CN¥6.09 |
52 Week Low | CN¥4.28 |
Beta | 0.30 |
11 Month Change | 4.55% |
3 Month Change | -18.82% |
1 Year Change | -13.60% |
33 Year Change | -2.23% |
5 Year Change | -14.96% |
Change since IPO | -51.99% |
Recent News & Updates
Is C.Q. Pharmaceutical Holding (SZSE:000950) Using Too Much Debt?
Jul 13C.Q. Pharmaceutical Holding Co., Ltd. (SZSE:000950) Doing What It Can To Lift Shares
Jun 11Shareholder Returns
000950 | CN Healthcare | CN Market | |
---|---|---|---|
7D | -1.2% | 1.2% | -0.3% |
1Y | -13.6% | -30.1% | -18.1% |
Return vs Industry: 000950 exceeded the CN Healthcare industry which returned -30.1% over the past year.
Return vs Market: 000950 exceeded the CN Market which returned -18.1% over the past year.
Price Volatility
000950 volatility | |
---|---|
000950 Average Weekly Movement | 3.9% |
Healthcare Industry Average Movement | 4.7% |
Market Average Movement | 5.6% |
10% most volatile stocks in CN Market | 8.9% |
10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 000950's share price has been volatile over the past 3 months.
Volatility Over Time: 000950's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 14,485 | Wei Liu | www.cqphar.com |
C.Q. Pharmaceutical Holding Co., Ltd. distributes pharmaceutical products. The company engages in the research, development, production, and investment for medical device in the pharmaceutical industry. It offers medicines, medical devices, Chinese herbal medicines, health care products, hospital sales, and commercial wholesale, retail chain; terminal distribution; warehousing logistics; and supply chain value-added services.
C.Q. Pharmaceutical Holding Co., Ltd. Fundamentals Summary
000950 fundamental statistics | |
---|---|
Market cap | CN¥8.35b |
Earnings (TTM) | CN¥591.87m |
Revenue (TTM) | CN¥80.12b |
14.1x
P/E Ratio0.1x
P/S RatioIs 000950 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
000950 income statement (TTM) | |
---|---|
Revenue | CN¥80.12b |
Cost of Revenue | CN¥73.95b |
Gross Profit | CN¥6.17b |
Other Expenses | CN¥5.58b |
Earnings | CN¥591.87m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 21, 2024
Earnings per share (EPS) | 0.34 |
Gross Margin | 7.71% |
Net Profit Margin | 0.74% |
Debt/Equity Ratio | 149.1% |
How did 000950 perform over the long term?
See historical performance and comparison